-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, with jurisdictional netting.
-
Summary
-
Protalix BioTherapeutics, Inc. quarterly Deferred Income Tax Assets, Net history and growth rate from Q4 2022 to Q3 2024.
- Protalix BioTherapeutics, Inc. Deferred Income Tax Assets, Net for the quarter ending September 30, 2024 was $2.86M, a 7.63% decline year-over-year.
Deferred Income Tax Assets, Net, Quarterly (USD)
Deferred Income Tax Assets, Net, YoY Quarterly Growth (%)